WFA
XBI icon

WestHill Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WestHill Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300
Closed -$21.9K – 116
2023
Q3 		$21.9K Buy
+300
New +$24K 0.01% 96

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

WestHill Financial Advisors's XBI Position: Q4 2023 in Review

WestHill Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 300 shares — an estimated $21.9K sold.

WestHill Financial Advisors first reported a position in XBI in Q3 2023 and held it in 1 quarter. The position peaked at $21.9K in Q3 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • WestHill Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • WestHill Financial Advisors sold 300 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $21.9K.
  • WestHill Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 1 quarter.
  • WestHill Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $21.9K in Q3 2023.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on WestHill Financial Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.